Brief: Horizon Therapeutics Posts Q1 EPS of USD 0.23
03/05/2023 12:53
May 3 (Reuters) - Horizon Therapeutics Q1 sales USD 832.1 million. * Q1 EPS USD 0.23 * Q1 adjusted EPS USD 0.83 * Q1 adjusted EBITDA USD 232.9 million * Q1 adjusted net income USD 194.3 million
Recent news on Horizon Therapeutics
See all newsDeals of the day-Mergers and acquisitions
Amgen completes $27.8 bln Horizon deal (updated)
Amgen completes acquisition of Horizon Therapeutics
Brief: Amgen Completes Acquisition Of Horizon Therapeutics PLC
On October 5, Court Sanctioned The Scheme Of Arrangement Under Chapter 1 Of Part 9 Of The Irish Companies Act 2014